First Approved BNCT Case in China: Pengbo Boron Neutron Hospital Treats Recurrent Tongue Cancer

Boao Lecheng reports that after starting trial operations in early February, Pengbo (Hainan) Boron Neutron Hospital completed the first clinical use of China’s first approved BNCT treatment system on 19 March—for a patient from Henan with advanced recurrent tongue cancer. Points below are source claims. Confirm indication, outcomes expectations, and price in writing. Not medical advice.

Boron neutron capture therapy (BNCT) is framed in the post as precision radiotherapy—“highly targeted,” with notable efficacy and relatively low side effects, often needing only one irradiation. Treat that as marketing language; individual results vary.

Under Lecheng’s pilot-first policy, the hospital says it is cleared for unresectable locally advanced or recurrent head-and-neck cancers, covering nasopharyngeal, paranasal sinus, laryngeal, oral cavity, tongue, gingival, and parotid cancers, secondary neck malignancies, and more than ten subtypes in total. Eligibility is case-by-case.

First case and team remarks (as stated)

Wang Enmin said the session ran “smoother and shorter than prior simulations.” The post says the first case validated the team’s technical readiness and operating workflow and completed the path from importing BNCT drugs/devices through training to clinical use; follow-up efficacy assessment and scheduled visits are planned.

Looking ahead, the hospital aims to use Lecheng policy advantages to offer more eligible patients a less invasive, faster-recovery, high-precision option and to become a BNCT hub in China and Asia. The pilot zone says it will support building a globally influential BNCT center. Confirm license, indication, and a written estimate before travel.

The Boao Lecheng International Medical Tourism Pilot Zone, approved by the State Council in February 2013, pilots franchised medical care, oncology, and health management—aiming for “three synchronizations” of technology, equipment, and drugs with international standards.